Bank of New York Mellon Corp - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 96 filers reported holding GW PHARMACEUTICALS PLC in Q1 2015. The put-call ratio across all filers is 0.66 and the average weighting 0.3%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q1 2021$3,840,000
-91.4%
17,705
-95.4%
0.00%
-90.0%
Q4 2020$44,746,000
+21.6%
387,707
+2.6%
0.01%
+11.1%
Q3 2020$36,801,000
-19.5%
378,033
+1.5%
0.01%
-25.0%
Q2 2020$45,715,000
+106.3%
372,528
+47.2%
0.01%
+71.4%
Q1 2020$22,164,000
+3.6%
253,107
+23.7%
0.01%
+16.7%
Q4 2019$21,393,000
+17.9%
204,595
+29.6%
0.01%
+20.0%
Q3 2019$18,152,000
-28.7%
157,812
+6.8%
0.01%
-28.6%
Q2 2019$25,469,000
+3.7%
147,740
+1.4%
0.01%0.0%
Q1 2019$24,572,000
+74.3%
145,771
+0.7%
0.01%
+75.0%
Q4 2018$14,098,000
+789.5%
144,768
+1478.9%
0.00%
Q3 2018$1,585,000
-13.0%
9,169
-29.8%
0.00%
Q2 2018$1,822,000
+190.6%
13,053
+134.9%
0.00%
Q1 2018$627,000
-10.6%
5,557
+4.6%
0.00%
Q4 2017$701,000
-97.5%
5,313
-97.7%
0.00%
-100.0%
Q1 2017$28,279,000
-44.5%
233,831
-48.7%
0.01%
-46.7%
Q4 2016$50,939,000
-49.6%
455,827
-40.1%
0.02%
-50.0%
Q3 2016$101,030,000
+18.8%
761,172
-18.1%
0.03%
+15.4%
Q2 2016$85,053,000
+3.6%
928,836
-18.4%
0.03%
+4.0%
Q1 2016$82,127,000
+20.4%
1,138,280
+15.9%
0.02%
+19.0%
Q4 2015$68,201,000
-8.2%
982,158
+20.8%
0.02%
-8.7%
Q3 2015$74,278,000
-16.4%
812,940
+12.4%
0.02%
-4.2%
Q2 2015$88,809,000
+42.8%
722,969
+5.9%
0.02%
+50.0%
Q1 2015$62,198,000
+859.4%
682,523
+612.5%
0.02%
+700.0%
Q4 2014$6,483,000
+734.4%
95,787
+896.7%
0.00%
Q3 2014$777,0009,6100.00%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q1 2015
NameSharesValueWeighting ↓
VHCP Management, LLC 311,853$25,213,00011.33%
Iguana Healthcare Management, LLC 50,000$4,043,0002.16%
Ghost Tree Capital, LLC 35,000$2,830,0001.54%
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD 354,278$28,643,0001.06%
Cupps Capital Management, LLC 100,213$8,102,0000.75%
CLOUGH CAPITAL PARTNERS L P 192,600$15,572,0000.58%
FARALLON CAPITAL MANAGEMENT LLC 244,000$19,727,0000.32%
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD 105,200$8,505,0000.31%
Eventide Asset Management 25,000$2,021,0000.28%
PRUDENTIAL PLC 836,124$67,601,0000.28%
View complete list of GW PHARMACEUTICALS PLC shareholders